Stock Track | BioMarin Pharmaceutical Soars 5.30% Intraday on Positive Analyst Ratings and Upcoming Investor Conferences

Stock Track

02/24

BioMarin Pharmaceutical's stock surged 5.30% during intraday trading on Tuesday, following a series of positive analyst updates and the company's announcement of increased investor engagement.

The price movement comes after Evercore ISI and Cantor Fitzgerald both reaffirmed their Buy ratings on the stock, with price targets of $110 and $85 respectively. Additionally, Oppenheimer maintained coverage with a revised price target of $95, down from $98, while still indicating a positive outlook.

Investor sentiment was further bolstered by BioMarin's announcement that its management will participate in four investor conferences in March 2026, including events hosted by TD Cowen, Leerink, Jefferies, and Barclays. These appearances are expected to enhance the company's visibility and communication with the investment community.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1104772958"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1104772958\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1104772958?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-24 22:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104772958","market":"hk","top_or_hot":-1,"title":"Stock Track | BioMarin Pharmaceutical Soars 5.30% Intraday on Positive Analyst Ratings and Upcoming Investor Conferences","media":"Stock Track","content":"<p>BioMarin Pharmaceutical's stock surged 5.30% during intraday trading on Tuesday, following a series of positive analyst updates and the company's announcement of increased investor engagement.</p><p>The price movement comes after Evercore ISI and Cantor Fitzgerald both reaffirmed their Buy ratings on the stock, with price targets of $110 and $85 respectively. Additionally, Oppenheimer maintained coverage with a revised price target of $95, down from $98, while still indicating a positive outlook.</p><p>Investor sentiment was further bolstered by BioMarin's announcement that its management will participate in four investor conferences in March 2026, including events hosted by TD Cowen, Leerink, Jefferies, and Barclays. These appearances are expected to enhance the company's visibility and communication with the investment community.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | BioMarin Pharmaceutical Soars 5.30% Intraday on Positive Analyst Ratings and Upcoming Investor Conferences</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | BioMarin Pharmaceutical Soars 5.30% Intraday on Positive Analyst Ratings and Upcoming Investor Conferences\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-24 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioMarin Pharmaceutical's stock surged 5.30% during intraday trading on Tuesday, following a series of positive analyst updates and the company's announcement of increased investor engagement.</p><p>The price movement comes after Evercore ISI and Cantor Fitzgerald both reaffirmed their Buy ratings on the stock, with price targets of $110 and $85 respectively. Additionally, Oppenheimer maintained coverage with a revised price target of $95, down from $98, while still indicating a positive outlook.</p><p>Investor sentiment was further bolstered by BioMarin's announcement that its management will participate in four investor conferences in March 2026, including events hosted by TD Cowen, Leerink, Jefferies, and Barclays. These appearances are expected to enhance the company's visibility and communication with the investment community.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BMRN","symbol_name":"拜玛林制药","start_time":0,"source_url":"","article_id":"1104772958","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104772958","pubTimestamp":1771944414,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"BioMarin Pharmaceutical's stock surged 5.30% during intraday trading on Tuesday, following a series of positive analyst updates and the company's announcement of increased investor engagement.The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BMRN":"拜玛林制药"},"translate_title":"个股追踪|拜玛林制药盘中大涨5.30%，因分析师正面评级和即将召开的投资者会议","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BMRN":1},"content_text":"BioMarin Pharmaceutical's stock surged 5.30% during intraday trading on Tuesday, following a series of positive analyst updates and the company's announcement of increased investor engagement.The price movement comes after Evercore ISI and Cantor Fitzgerald both reaffirmed their Buy ratings on the stock, with price targets of $110 and $85 respectively. Additionally, Oppenheimer maintained coverage with a revised price target of $95, down from $98, while still indicating a positive outlook.Investor sentiment was further bolstered by BioMarin's announcement that its management will participate in four investor conferences in March 2026, including events hosted by TD Cowen, Leerink, Jefferies, and Barclays. These appearances are expected to enhance the company's visibility and communication with the investment community.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}